Beginning January 1, 2022, Medicare Advantage Organizations (MAOs) and Medicare-Medicaid Plans (MMPs) are responsible for adjudicating claims for COVID-19 vaccines and their administration and for
COVID-19 monoclonal antibodies and their administration.

 

EBSCRNU-0210-21 October 2021



Featured In:
December 2021 Newsletter